Iodine uptake patterns on post-ablation whole body scans are related to elevated serum thyroglobulin levels after radioactive iodine therapy in patients with papillary …

GC Jeong, M Song, HJ Park, JJ Min, HS Bom… - Nuclear medicine and …, 2016 - Springer
Abstract Purpose Serum thyroglobulin (Tg) level is frequently elevated shortly after
radioactive iodine (RAI) ablation therapy. The authors studied the relationship between the …

Quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer.

U Abdulrezzak, A Tutus, I Isik, Y Kurt… - The Quarterly Journal of …, 2015 - europepmc.org
Background The aim of this paper was to compare the results of postoperative I-131 remnant
ablation therapy using a quantitative data in the low activity (1110 MBq) and standard dose …

Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by 131I-SPECT/CT at the first …

D Schmidt, R Linke, M Uder, T Kuwert - European journal of nuclear …, 2010 - Springer
Purpose In differentiated thyroid carcinoma (DTC), 131 I-SPECT/CT is more accurate in
identifying radioiodine-positive lymph node metastases (LNM) than planar whole-body …

Prospective randomised trial for the evaluation of the efficacy of low vs. high dose I-131 for post operative remnant ablation in differentiated thyroid cancer

S Sirisalipoch, V Buachum, P Pasawang… - World Journal of …, 2004 - inis.iaea.org
[en] This study was performed under the auspices of IAEA project (i) to evaluate the efficacy
of low (50 mCi) vs. high (100 mCi) dose I-131 for post operative remnant ablation in …

Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation

A Vrachimis, O Schober… - Nuklearmedizin …, 2012 - thieme-connect.com
Aim: Radioiodine remnant ablation (RRA) after (near-) total thyroidectomy (TE) is a key
element in patients with differentiated thyroid cancer (DTC). The use of exogenous TSH …

Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high‐risk differentiated thyroid cancer

F Pitoia, RJ Marlowe, E Abelleira… - Journal of Thyroid …, 2012 - Wiley Online Library
To supplement limited relevant literature, we retrospectively compared ablation and disease
outcomes in high‐risk differentiated thyroid carcinoma (DTC) patients undergoing …

Radioiodine remnant ablation: a critical review

C Bal, A Padhy - World Journal of Nuclear Medicine, 2015 - thieme-connect.com
Radioiodine remnant ablation (RRA) is considered a safe and effective method for
eliminating residual thyroid tissue, as well as microscopic disease if at all present in thyroid …

[HTML][HTML] Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

SKA Súss, CO Mesa Jr, GA Carvalho… - … of Endocrinology and …, 2018 - SciELO Brasil
Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk
thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine …

Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario

A Campennì, L Giovanella, SA Pignata… - Nuclear Medicine …, 2015 - journals.lww.com
Objective Differentiated thyroid cancer is rare, but the incidence has been increasing in the
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …

Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer

AS Alzahrani, G Mohamed, A Al Shammary… - Journal of …, 2005 - Springer
Following the initial management, some patients with differentiated thyroid cancer (DTC)
develop a state of high thyroglobulin (Tg) and negative diagnostic radioactive iodine (RAI) …